ClinicalTrials.gg
RecruitingNCT07774949Updated Aug 19, 2026

Association of Maternal Thyroid Function and Anxiety With Fetal Cardiotocography Parameters in High-Risk Pregnancies

An observational study in High-risk Pregnancy, sponsored by Istanbul Training and Research Hospital. Recruiting at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-08-19.

Sponsored by Istanbul Training and Research Hospital · Observational

From the registry’s dates

  • Started Mar 2026; still recruiting 7 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

This prospective observational study aims to investigate the association between maternal thyroid function, maternal anxiety levels, and fetal cardiotocography parameters in high-risk pregnancies. Pregnant women at 32 weeks of gestation or later who are followed in the perinatology outpatient clinic for high-risk pregnancy will be included.

Maternal thyroid function test results, including thyroid-stimulating hormone (TSH) and free thyroxine (fT4), obtained as part of routine clinical care will be recorded. Maternal anxiety will be assessed using the Beck Anxiety Inventory. Fetal well-being will be evaluated using a routine 20-minute non-stress test (NST), including baseline fetal heart rate, accelerations, reactivity, and the presence of decelerations.

The associations between maternal anxiety scores, thyroid hormone levels and thyroid status, and fetal cardiotocography parameters will be analyzed. Sociodemographic and obstetric characteristics will also be evaluated in relation to these parameters.

02

Conditions studied

  • High-risk Pregnancy

Keywords

  • High-risk pregnancy
  • Maternal anxiety
  • Thyroid dysfunction
  • Cardiotocography
  • Beck Anxiety Inventory
03

In context

Lead sponsor

Istanbul Training and Research Hospital is the lead sponsor of 66 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population will consist of women with high-risk singleton pregnancies at 32 weeks of gestation or later who are followed at the Perinatology Outpatient Clinic of Istanbul Training and Research Hospital and who undergo routine thyroid function testing and non-stress testing.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Singleton pregnancy at 32 weeks of gestation or later
  • Pregnancy being followed as a high-risk pregnancy
  • Age between 18 and 45 years
  • Availability of routine thyroid function test results and non-stress test assessment
  • Ability and willingness to provide written

Exclusion criteria

Exclusion Criteria:

  • Gestational age below 32 weeks
  • Multiple pregnancy
  • Fetal conditions that may affect interpretation of the non-stress test tracing
  • Acute maternal infection
  • Presence of an acute obstetric condition
  • Previously diagnosed psychiatric disorder
  • Current use of psychiatric medication
  • Age younger than 18 years or older than 45 years
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Patient registry
No

Groups and cohorts

  • High-Risk Pregnant Women

    Pregnant women with singleton high-risk pregnancies at 32 weeks of gestation or later who undergo routine thyroid function testing and non-stress testing as part of their clinical follow-up. Maternal anxiety will be assessed using the Beck Anxiety Inventory.

06

What researchers measure

Primary outcomes

  1. Association Between Maternal Anxiety Level and NST Parameters

    The association between Beck Anxiety Inventory scores and fetal non-stress test parameters will be evaluated.

    Time frame: At study enrollment, during the same-day assessment

  2. Association Between Maternal Thyroid Function and NST Parameters

    The association between maternal TSH and free T4 levels and fetal non-stress test parameters will be evaluated.

    Time frame: At study enrollment, using third-trimester thyroid function test results and same-day NST assessment

Secondary outcomes

  1. Association of Sociodemographic and Obstetric Characteristics With Maternal Anxiety, Thyroid Function, and NST Parameters

    Time frame: At study enrollment, using third-trimester thyroid function test results and same-day NST and anxiety assessment

07

Study locations

1 of 1 sites recruiting
  • Istanbul Training and Research Hospital
    Istanbul, Turkey (Türkiye)
    Recruiting
    • Doruk C Katlan · Contactdcek2000@yahoo.com · +905353475411
    • Nebahat Uzunay · Sub investigator
    • Filiz Değirmenci · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 19, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07774949
Lead sponsor
Istanbul Training and Research Hospital
Responsible party
Doruk Cevdi Katlan (Maternal Fetal Medicine Specialist, Istanbul Training and Research Hospital) — Principal investigator
First posted
Aug 19, 2026
Start date
Mar 27, 2026
Primary completion
Apr 2028 (estimated)
Completion
Dec 2028 (estimated)
Last update
Aug 19, 2026

Study contacts

Doruk C Katlan
Contact
dcek2000@yahoo.com
+905353475411

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion